Scioto Biosciences is a Clinical stage biotech company dedicated to innovative research and discovery in the field of microbiome therapeutics. Our team has developed a proprietary Activated Bacterial Therapeutics (ABT) platform for delivering best-in-class, live therapeutic bacteria to the gut. Our solution is focused on the activation of beneficial bacteria that have the potential to advance healing for various diseases associated with the GI tract, Oncology and CNS indications.
Looking for a particular Scioto Biosciences, Inc employee's phone or email?
The Scioto Biosciences, Inc annual revenue was $10 million in 2026.
Joseph Trebley is the CEO of Scioto Biosciences, Inc.
4 people are employed at Scioto Biosciences, Inc.
Scioto Biosciences, Inc is based in Indianapolis, Indiana.
The NAICS codes for Scioto Biosciences, Inc are [541714, 541, 5417, 54, 54171].
The SIC codes for Scioto Biosciences, Inc are [87, 873].